These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 29665316)

  • 1. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical implication of S100A12 in gastric carcinoma.
    Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
    Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma.
    Zeng Z; Wu HX; Zhan N; Huang YB; Wang ZS; Yang GF; Wang P; Fu GH
    Tumour Biol; 2014 Apr; 35(4):3845-53. PubMed ID: 24343337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
    Gao C; Yao H; Liu H; Feng Y; Yang Z
    BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
    Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
    Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
    Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
    Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
    Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of increased expression of RBM8A in gastric cancer.
    Lv X; Cheng H
    Braz J Med Biol Res; 2020; 53(4):e9290. PubMed ID: 32294703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane-4-L-six-family-1, a potential predictor for poor prognosis, overexpressed in human glioma.
    Wang P; Bao W; Zhang G; Cui H; Shi G
    Neuroreport; 2015 May; 26(8):455-61. PubMed ID: 25855954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.
    Li D; Zhang J; Xi Y; Zhang L; Li W; Cui J; Xing R; Pan Y; Pan Z; Li F; Lu Y
    BMC Cancer; 2015 Sep; 15():637. PubMed ID: 26373288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway.
    Wei Y; Yin L; Xie X; Wu Z; Zhang J; Gao Y; Tang J
    Mutat Res; 2022; 825():111802. PubMed ID: 36274500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
    Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
    PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
    Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD
    Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.